Milestones  
1996
Set up Desano
 
1998
Set up R&D team to research and develop APIs of ARVs, oncology and steroids
 
2000
Formulations of ARV generic drugs were developed
 
2001
APIs and Formulations were manufactured and commercialized
 
2002
ARV generic drugs manufactured obtained market authorization in China
 
2003
Two Subsidiary pharmaceutical companies got GMP certificate to become one of the first domestic supplier of ARV generic drugs in China
 
2004
Set up overseas branches to introduce Desano's brand internationally
 
2005
R&D Center is honored to be Shanghai Enterprise Technology Center
 
2007

Passed WHO-PQ inspection

 
2009

Passed US FDA inspection